Biotech Investing, Healthcare Stocks, FDA Calendar

Featured Content Exelixis Prepares for ASCO 2013, Stock Stays Rangebound One of the biopharmaceutical companies that has been lagging the stellar performance of its peers is Exelixis (NADSAQ: EXEL), developer of the compound cabozantinib. » Read More Amarin Stays Rangebound, Prescriptions Stagnate Amarin Corporation (NASDAQ: AMRN) has been struggling a lot lately as retail channel prescription data for its EPA capsule Vascepa imply that the drug is starting to slow down its momentum in the MARINE indication (hypertriglyceridemia patients with >500 mg/dL). » Read More Vivus Heats Up, Shorts Discouraged on Possible Bidding War Vivus (NASDAQ: VVUS) has been seeing relatively modest growth in QSYMIA (phentermine and topiramate ER) prescriptions since the drug launched in September 2012 under the FDA’s REMS agreement, which restricted the drug’s sales significantly due to the inability for patients to have prescriptions for the drug filled at brick-and-mortar pharmacies. » Read More Subscriber Only Content » Read More Date: 6th May 2013 Carving out a Distinct Niche This research article is being releases to our premium subcribers first. » Read More Date: 20th February 2013 Watch this one closely, It could rise more quickly than expected. We are alerting our premium subscribers first on the potential for a nice upside trade potantial of ... » Read More Date: 5th February 2013 Things May Get Interesting Here This information is posted for our premium subscribers first.	Sector News Omeros Announces INDA for OMS824 Cleared by FDA; Celgene Announces FDA Grants Priority Review for ABRAXANE Below is a look at some of the headlines for companies that made news in the healthcare sector on May 23, 2013. » Read More Healthcare Review: Apricus Biosciences, MannKind Corporation, Elan Corporation, Rexahn Pharmaceuticals, Breezer Ventures U.S. stocks slipped on Thursday, recovering from session lows as encouraging domestic economic data and a rally in Hewlett-Packard's shares offset concerns about the timing of any reduction in the Federal Reserve's monetary stimulus. » Read More Boston Scientific Announces Results from Promus Premier; Salix's Budesonide Foam Shows Significant Results Below is a look at some of the headlines for companies that made news in the healthcare sector on May 22, 2013. » Read More Healthcare Review: MannKind Corporation, NPS Pharmaceuticals, Ariad Pharmaceuticals, Bristol Myers Squibb, Celsion Corporation U.S. stocks fell, erasing an early rally, as investors weighed remarks by Federal Reserve Chairman Ben S. Bernanke and minutes from the central bank’s latest policy meeting about the pace of stimulus efforts. U.S. stocks rallied early in the day after Bernanke said in prepared remarks to Congress that a premature withdrawal of quantitative easing would put the economic recovery at risk. » Read More CytRx Offers Initial Results from Aldoxorubicin Trial; Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent Below is a look at some of the headlines for companies that made news in the healthcare sector on May 21, 2013. » Read More

Next Prev Breaking News Patient Home Monitoring (PHM) Announces An Update On Progress to Improve Gross Margin and Revenue Gr... SAN FRANCISCO, CALIFORNIA--(Marketwired - May 24, 2013) -Patient Home Monitoring (PHM) (TSX VENTU... Read more Building Medical Affairs Capabilities to Ensure Organizational Success across Key Operational Areas CHAPEL HILL, N.C., May 24, 2013/... Read more SFT Introduces Critical Semiconductor Design Products for ESD Electro-Thermal Analysis SOURCE: Silicon Frontline Technology Read more Healthtech Assists Clients With Sector-Wide Challenges TORONTO, ONTARIO--(Marketwired - May 24, 2013) - Editors' Note: There is a photo associate with ... Read more The Cooper Institute Signs Agreement With Hungarian School Sport Federation SOURCE: The Cooper Institute Read more Makers of CALPOL(R) Launch a Unique App for the iPhone, Providing Mums With a Helping Hand Whilst Ge... Pioneering the way in child's health support, makers of CALPOL® develop first of its kind app for t... Read more joimax® Presents EndoLIF® as a World Premiere at the Annual Meeting of DGNC KARLSRUHE, Germany, May 24, 2013... Read more Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology SOURCE: Quincy Bioscience MADISON, WI--(Marketwired - May 24, 2013) - Quincy Bioscience, a lea... Read more InspireMD To Participate In Benchmark Investor Conference On May 30th BOSTONand TEL AVIV, Israel, May ... Read more International Field for Hope Campaign Plants HOPE; Seeks to End the Stigma of Depression SOURCE: International Foundation for Education and Research on Depression Supporters From Around... Read more SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE Senomyx logo. (PRNewsFoto/Senomyx, Inc.... Read more BioNJ Announces Keynote Speakers for BioP 4th Annual International BioPartnering Conference Christopher P. Austin, M.D., Director, National Center for Advancing Translational Sci... Read more Research and Markets: PharmaPoint: Multiple Sclerosis - India Drug Forecast and Market Analysis to 2... Research and MarketsLaura Wood, Senior Manager.... Read more Research and Markets: PharmaPoint: Multiple Sclerosis - Italy Drug Forecast and Market Analysis to 2... Research and MarketsLaura Wood, Senior Manager.... Read more Research and Markets: Global Acute Coronary Syndrome Pipeline Capsule - 2013 Research and MarketsLaura Wood, Senior Manager.... Read more Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United S... NEW YORK, May 24, 2013/PRNewswire/ -- In accordance... Read more Sangamo BioSciences Receives $6.4 Million Strategic Partnership Award From California Institute for ... RICHMOND, Calif., May 24, 2013/P... Read more Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference Auxilium Pharmaceuticals, Inc. Logo. (P... Read more